Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ClearPoint Neuro, Inc.

Get SEC filing alerts via email and in your feed for ClearPoint Neuro, Inc.

CLPT

ClearPoint Neuro, Inc.

About ClearPoint Neuro, Inc.

ClearPoint Neuro develops and commercializes minimally invasive neurosurgical devices, primarily the ClearPoint system for MRI-guided brain procedures, including electrode placement, biopsies, and laser therapies. The company also partners in biologics and drug delivery, supporting research and clinical trials for brain-targeted therapies. Its products serve global markets, emphasizing innovation, regulatory compliance, and a strong intellectual property portfolio to enhance neurosurgical outcomes.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ClearPoint Neuro, Inc.

1
1
ClearPoint Neuro, Inc. ClearPoint Neuro Reports 43% Revenue Growth to $12.1 Million in Q1 2026

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
ClearPoint Neuro, Inc. ClearPoint Neuro Reports $37M Revenue for Fiscal Year 2025, Faces Increased Net Loss

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
ClearPoint Neuro, Inc. ClearPoint Neuro Reports 20% Revenue Growth to $5.2 Million, Improves Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ClearPoint Neuro, Inc. ClearPoint Neuro Reports 17% Revenue Growth in Q2 2025, Faces Increased Net Loss

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
ClearPoint Neuro, Inc. ClearPoint Neuro Reports 11% Revenue Growth to $8.5 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
ClearPoint Neuro, Inc. ClearPoint Neuro Reports $31.4 Million Revenue for Fiscal Year 2024, Driven by Product Sales Growth

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
ClearPoint Neuro, Inc. ClearPoint Neuro Reports 41% Revenue Growth, Improved Gross Profit in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments